組織処理システムの世界市場-2023年～2030年

市場概要

世界の組織処理システム市場は、2022年に3億8,320万米ドルに達し、2023-2030年の予測期間にCAGR 5.4%で成長し、2030年には5億7,860万米ドルに達すると予測されています。世界の組織処理システム市場は、高齢化人口の増加、生活習慣病の増加、技術の進歩、アクセスしやすく質の高い医療オプションを提供するための政府の取り組み強化など、さまざまな要因によって牽引されています。

組織処理には、固定した動物やヒトの組織をミクロトームに移し、組織ワックス移植や切片切断を行うことが含まれます。この中には、細胞から水分を除去し、凍結培地に置き換えて薄切片にすることも含まれています。適切な修復の後、組織は脱水・洗浄・浸潤を受けます。

組織学研究室での組織処理には、疾病診断のための身体組織の準備や、病理医が顕微鏡で見るための顕微鏡スライド作製が含まれ、その技術には生検、外科検体、剖検組織などがあります。組織検査技師は組織処理とガラス製顕微鏡スライドを扱います。

市場力学

がん疾患の有病率の上昇

がんの有病率の上昇は、予測期間中に市場が成長するための重要な要因の1つです。組織処理システムは、がん診断ラボで広く使用されています。生検サンプルは、がん診断のために組織処理装置で処理されます。組織処理装置は、大量のサンプルを管理し、サンプルを迅速に処理し、高品質の結果を出すことができます。

これらのシステムは、病理検査、診断、調査のための組織サンプルの調製と処理において重要な役割を果たしています。正確で効率的ながん診断と治療の必要性が高まるにつれ、組織処理装置は検査室や医療施設にとって不可欠なツールとなっています。

例えば、米国がん協会のデータによると、2023年には米国で新たに1,958,310人のがん患者が発生し、約609,820人ががんで死亡すると予測されており、これは1日当たり約1,670人の死亡に相当します。米国では、がんは心臓病に次いで2番目に多い死因です。

技術進歩

組織処理手順は近年かなり改善されてきています。組織処理装置の自動化には、流体循環の改善、時間の節約、温度制御など、いくつかの利点があります。自動組織処理装置のその他の利点には、組織処理の大幅な向上、自動洗浄サイクル、試薬管理システムなどがあります。さらに、人為的ミスの減少にも役立ちます。このことは、技術的に洗練された組織処理装置の受容性を高め、組織処理装置に対する需要を増大させています。

訓練された専門家の不足

組織処理システム市場における訓練された専門家の不足は、専門スキルセット、教育プログラム、医学研究、診断、バイオテクノロジーにおける専門家への需要の高まりといった要因によるものです。組織処理装置、ミクロトーム、染色機など、装置が複雑なため、熟練した実務者の数はさらに限られています。

この問題に対処するためには、専門教育、専門能力開発への投資、社会的認識、研究協力、実習やインターンシップの取り組みなど、学術界、産業界、専門機関の協力が必要です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • がん疾患の有病率の上昇
    • 技術進歩
  • 抑制要因
    • 訓練を受けた専門家の不足
  • 機会
    • 個別化医療への注目の高まり
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 COVID-19分析

第7章 製品別

• 小容量組織処理装置
• 中容量組織処理装置
• 大容量組織処理装置

第8章 モダリティ別

• 卓上型組織処理装置
• 携帯型組織処理装置

第9章 技術別

• マイクロ波組織処理装置
• 真空式組織処理装置

第10章 エンドユーザー別

• 病院
• 学術研究機関
• 診断検査室
• その他

第11章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • その他アジア太平洋
• 中東・アフリカ
  • 地域別の主な動向

第12章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第13章 企業プロファイル

• Danaher（Leica Biosystems Nussloch GmbH）
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な動向
• JOKOH
• Medite Medical GmbH
• Milestone SRL
• Sakura Finetek USA, Inc.
• SLEE medical GmbH
• Bio Optica
• Histo-Line Laboratories
• General Data Company Inc
• Unimeditrek

第14章 付録

Market Overview

Global Tissue Processing Systems Market reached US$ 383.2 million in 2022 and is expected to reach US$ 578.6 million by 2030 growing with a CAGR of 5.4% during the forecast period 2023-2030. The global tissue processing systems market is driven by various factors like an increase in the ageing population, an rise in lifestyle diseases, technological advancements, and rising government initiatives to provide accessible and high-quality healthcare options.

Tissue processing involves transferring fixed animal or human tissue to a microtome for histological wax implantation and section cutting. It involves removing water from cells and replacing it with frozen media for thin slices. After proper repair, the tissue undergoes dehydration, cleansing and infiltration.

Tissue processing in the histology laboratory involves preparing body tissues for disease diagnosis and producing microscopic slides for pathologists to view under a microscope and techniques include biopsies, surgical specimens, and autopsy tissues. Histotechnologists handle tissue processing and glass microscopic slides.

Market Dynamics

Rise in the Prevalence of Cancer Diseases

The rise in the prevalence of cancer is one of the key factors that helps the market to grow during the forecast period. Tissue processing systems are widely used in cancer diagnostic laboratories. Biopsy samples are processed in tissue processors for cancer diagnosis. They can manage a large number of samples, quickly process the samples, and produce high-quality results.

These systems play a crucial role in preparing and processing tissue samples for pathological examination, diagnosis, and research. As the need for accurate and efficient cancer diagnosis and treatment grows, tissue processor systems become essential tools for laboratories and healthcare facilities.

For instance, according to American Cancer Society data, in 2023 there are projected to be 1,958,310 new cancer cases and approximately 609,820 deaths from cancer are expected in the US in 2023 which is about 1,670 deaths per day. Cancer is the second most common cause of death in the US, exceeded only by heart disease.

Rise in Technological Advancements

Tissue processing procedures have been considerably improved in recent years. Tissue processor automation has several advantages, including improved fluid circulation, time savings, and temperature control. Other advantages of automated tissue processors include greatly enhanced tissue processing, automatic cleaning cycles, and reagent management systems. Furthermore, it aids in the reduction of human mistakes. This raises the acceptability of technologically sophisticated tissue processors, hence increasing demand for tissue processing equipment.

Lack of Trained Professionals

The shortage of trained professionals in the tissue processing systems market is due to factors like specialized skill sets, educational programs, and the growing demand for experts in medical research, diagnostics, and biotechnology. The intricate nature of equipment, such as tissue processors, microtomes, and staining machines, further limits the pool of skilled practitioners.

To address this issue, collaboration between academia, industry, and professional organizations is needed, including specialized education, investment in professional development, public awareness, research collaborations, and apprenticeship and internship initiatives.

For more details on this report - Request for Sample

Segment Analysis

The global tissue processing systems market is segmented based on product type, modality, technology, end user and region.

The Small Volume Tissue Processors From The Product Segment Accounted for Approximately 42.1 % of the Tissue Processing Systems Market Share

The small volume of tissue processors from the product segment with around 42.1% is expected to dominate during the forecast period. These are suitable for small laboratory sizes as well as also save space the factors supporting its demand and growth in the market. For instance, the Leica TP1020 semi-enclosed rotary processor is designed for reliability and economy. It can optimize laboratory space with the small footprint of the HistoCore PEARL tissue processor. It is a semi-enclosed benchtop tissue processor with small volumes (≤200 blocks/day).

Geographical Penetration

North America Accounted for Approximately 37.9% of the Market Share in 2022

North America is estimated to hold about 37.9% of the total market share throughout the forecast period, due to the launches of new tissue processors, technological advancements, expansion by key players, growing geriatric population along with adoption of innovative medical technology, rise in cancer incidence, and raising awareness about cancer screening in this region.

For instance, on 3rd February 2022, Leica Biosystems expanded its Dual-Retort Tissue Processor portfolio in North America with HistoCore PEGASUS. The main issue with tissue processing is processing biopsy and large routine specimens in the same run, causing under- or over-processing. In ideal scenarios, biopsy and larger sample tissues should be processed separately using a specific protocol.

Competitive Landscape

The major global players in the tissue processing systems market include JOKOH, Danaher(Leica Biosystems Nussloch GmbH), Medite Medical GmbH, Milestone SRL, Sakura Finetek USA, Inc., SLEE medical GmbH, Bio Optica, Histo-Line Laboratories, General Data Company Inc, Unimeditrek and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the histology equipment industry, limiting demand for slide staining and tissue processing systems. Clinical testing providers face logistical challenges such as transportation of tissue samples, access to microscopes, and IT systems. However, companies like Roche Digital Pathology have made decisive steps to overcome these challenges, offering a comprehensive solution for chronic illness diagnosis. This will likely significantly influence the worldwide tissue processing systems market.

Russia Ukraine Conflict Analysis

The Russia-Ukraine war significantly impacted the tissue processing systems market, causing supply chain disruptions and increased raw material costs. Sanctions from several countries cut supply while rising inflation presents new challenges for manufacturers.

By Product Type

• Small-volume tissue processors
• Medium Volume tissue processors
• High Volume tissue processors

By Modality

• Bench Top tissue processing unit
• Portable tissue processing unit

By Technology

• Microwave tissue processors
• Vaccum tissue processors

By End User

• Hospitals
• Academic and Research Institutes
• Diagnostic Laboratories
• Others

By Region

• North America

U.S.

Canada

Mexico

• Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

• South America

Brazil

Argentina

Rest of South America

• Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• In March 2023, Virscio, a leading provider of translational research and development services, launched a new Pathology and Tissue Pharmacodynamics Division to enhance preclinical drug development programs. The division, led by Dr Jennifer Cann and Richard Bouffard, offers comprehensive non-GLP, GLP, and GCLP histology and pathology services, including tissue processing, slide preparation, staining, immunohistochemistry, digital slide scanning, quantitative image analysis, and pathology interpretation.
• In September 2022, the histopathology company Sakura Finetek Europe announced the launch of its newest solution Tissue-Tek Genie, an advanced staining system, entering the market.
• In September 2020, Sakura Finetek USA, Inc. announced the launch of two new laser-printable tissue cassettes, broadening the Tissue-Tek Paraform Sectionable Cassette System for use on the Tissue-Tek AutoTEC a120 Automated Embedding Systems.

Why Purchase the Report?

• To visualize the global tissue processing systems market segmentation based on product type, modality, technology, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of tissue processing systems market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global tissue processing systems market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Modality
• 3.3. Snippet by Technology
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rise in the Prevalence of Cancer Diseases
    • 4.1.1.2. Rise in Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. Lack of Trained Professionals
  • 4.1.3. Opportunity
    • 4.1.3.1. Rise in Focus on Personalized Medicine
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post Covid-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product
• 7.2. Small Volume Tissue Processors *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Medium Volume Tissue Processors
• 7.4. High Volume Tissue Processors

8. By Modality

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 8.1.2. Market Attractiveness Index, By Modality
• 8.2. Bench Top Tissue Processing Unit*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Portable Tissue Processing Unit

9. By Technology

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.1.2. Market Attractiveness Index, By Technology
• 9.2. Microwave Tissue Processors *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Vaccum Tissue Processors

10. By End User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.1.2. Market Attractiveness Index, By End User
• 10.2. Hospitals *
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Academic and Research Institutes
• 10.4. Diagnostic Laboratories
• 10.5. Others

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. U.K.
    • 11.3.7.3. France
    • 11.3.7.4. Spain
    • 11.3.7.5. Italy
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan

Australia

• 11.5.7.4. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

• 13.1. Danaher(Leica Biosystems Nussloch GmbH)*
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. JOKOH
• 13.3. Medite Medical GmbH
• 13.4. Milestone SRL
• 13.5. Sakura Finetek USA, Inc.
• 13.6. SLEE medical GmbH
• 13.7. Bio Optica
• 13.8. Histo-Line Laboratories
• 13.9. General Data Company Inc
• 13.10. Unimeditrek

LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us